Our Company

Pioneering Health Advancement

With over 20 years of expertise in manufacturing and supplying specialized pharmaceuticals, our mission is to deliver globally innovative, high-quality treatments to Iranian patients.

Cobel darou

For more than 20 years, Cobel Darou has been operating with the aim of providing new treatment solutions for patients. Our main focus is to improve the health level of patients in different areas such as cardiovascular diseases, diabetes, oncology, respiratory, renal, neurological, orphan drugs, as well as medical devices.

Cobel darou

By improving the infrastructure and acquiring specialized knowledge, Cobel Darou has succeeded to gain the trust of the international pharmaceutical companies in the under-license production of important products inside the country. We are always trying to provide quality and innovative treatment solutions to the patients with the participation of international partners. We strive to always be a leader in the fields of development, product supply, training and support services through this cooperation.

Timeline

2001

Establishment of Cobel Darou

2003

Collaboration with Guerbet

2004

Collaboration with Piere Fabre

2005

Collaboration with MSD

2006

Collaboration with Sanofi

2008

Collaboration with Actelion
Collaboration with Uni Pharma
Collaboration with LFB
Moved to Local Production by acquiring 10% share of Abidi Lab

2009

Collaboration with AstraZeneca
Collaboration with Pharmathen
Under-License production of Sanofi-Aventis products

2010

Collaboration with Synthon

2011

Dermo cosmetic business with collaboration with L’oreal

2012

Production of Cobel Darou products
Collaboration with Biogen

2013

Collaboration with Roche Pharma

2017

Collaboration with GSK
Collaboration with Novartis

2018

Collaboration with Biologix

2019

Collaboration with Roche Diabetes Care

2021

Collaboration with Roche Diagnostics

2023

Sanofi New Business Model

2024

Collaboration with Advalvo